Outset Medical
San Jose, California, United States · Biotechnology, Healthcare, Health Care · 556 employees
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise s
Funding history
- Series seed — $3.9M — Jan 2025
- Funding Round — $115.0M — Feb 2020
- Funding Round — $131.7M — Aug 2018
- Series seed — $4.3M — Jun 2017
- Funding Round — $76.5M — May 2017
Recent signals
- Jun 03, 2025: Outset Medical Appoints Renee Gaeta as Chief Financial Officer
- Jan 21, 2025: Raised $3.9M in Series seed
- Jan 06, 2025: Outset Medical Announces $169 Million Private Placement Financing and New Debt Financing
- Feb 07, 2020: Raised $115.0M
- Aug 29, 2018: Raised $131.7M
- Jun 30, 2017: Raised $4.3M in Series seed
- May 03, 2017: Raised $76.5M
- May 20, 2015: Raised $59.6M
See plans & pricing → Track Outset Medical’s funding, hiring, and signals — with verified contacts — on Fundz.